# A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty

> **NCT05341115** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 80 (actual)

## Conditions studied

- Central Precocious Puberty

## Interventions

- **DRUG:** Leuprorelin Acetate Depot 3M

## Key facts

- **NCT ID:** NCT05341115
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-14
- **Primary completion:** 2024-12-19
- **Final completion:** 2025-03-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05341115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05341115, "A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05341115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*